[HTML][HTML] Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor
…, P Liu, L Gao, Z Li, Q Huang, L Xu, J Tang… - Cellular & molecular …, 2020 - nature.com
According to the World Health Organization (WHO) newly updated situation report on March
18th, 2020, the coronavirus disease 2019 (COVID-19) pandemic has confirmed 191,127 …
18th, 2020, the coronavirus disease 2019 (COVID-19) pandemic has confirmed 191,127 …
[HTML][HTML] Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19
…, L Gao, Z Li, Y Lin, Q Huang, L Xu, J Tang… - Signal transduction and …, 2020 - nature.com
COVID-19 patients exhibit differential disease severity after SARS-CoV-2 infection. It is
currently unknown as to the correlation between the magnitude of neutralizing antibody (NAb) …
currently unknown as to the correlation between the magnitude of neutralizing antibody (NAb) …
The kinase complex mTORC2 promotes the longevity of virus-specific memory CD4+ T cells by preventing ferroptosis
…, L Xu, J Hu, S Lei, Z Wei, Y Luo, Z Li, L Hu, J Tang… - Nature …, 2022 - nature.com
Antigen-specific memory CD4 + T cells can persist and confer rapid and efficient protection
from microbial reinfection. However, the mechanisms underlying the long-term maintenance …
from microbial reinfection. However, the mechanisms underlying the long-term maintenance …
[HTML][HTML] The transcription factor TCF1 preserves the effector function of exhausted CD8 T cells during chronic viral infection
…, Y Li, M Xiao, H Wang, Q Tian, Z Li, J Tang… - Frontiers in …, 2019 - frontiersin.org
The long-term persistence of viral antigens drives virus-specific CD8 T cell exhaustion during
chronic viral infection. Yet exhausted, CD8 T cells are still endowed with certain levels of …
chronic viral infection. Yet exhausted, CD8 T cells are still endowed with certain levels of …
[HTML][HTML] The dichotomous and incomplete adaptive immunity in COVID-19 patients with different disease severity
…, R Li, Z Pan, J Zhao, Z Li, Q Huang, J Tang… - Signal transduction and …, 2021 - nature.com
The adaptive immunity that protects patients from coronavirus disease 2019 (COVID-19),
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is not well …
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is not well …
Nasal spray of neutralizing monoclonal antibody 35B5 confers potential prophylaxis against severe acute respiratory syndrome coronavirus 2 variants of concern: a …
…, L Gao, J Zhou, Z Li, L Hu, J Tang… - Clinical Infectious …, 2023 - academic.oup.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of
concern (VOCs), especially the Delta and Omicron variants, have been reported to show …
concern (VOCs), especially the Delta and Omicron variants, have been reported to show …
Amorphous Oxysulfide Reconstructed from Spinel NiCo2S4 for Efficient Water Oxidation
YY Sun, XY Zhang, J Tang, X Li, HQ Fu, HG Xu, F Mao… - Small, 2023 - Wiley Online Library
The progress of effective and durable electrocatalysts for oxygen evolution reaction (OER) is
urgent, which is essential to promote the overall efficiency of green hydrogen production. To …
urgent, which is essential to promote the overall efficiency of green hydrogen production. To …
[HTML][HTML] The histone methyltransferase EZH2 primes the early differentiation of follicular helper T cells during acute viral infection
…, M Xiao, L Xie, S Tang, Z Liu, L Hu, J Tang… - Cellular & Molecular …, 2020 - nature.com
Epigenetic modifications to histones dictate the differentiation of naïve CD4 + T cells into
different subsets of effector T helper (T H ) cells. The histone methyltransferase enhancer of …
different subsets of effector T helper (T H ) cells. The histone methyltransferase enhancer of …
[HTML][HTML] An oncolytic virus delivering tumor-irrelevant bystander T cell epitopes induces anti-tumor immunity and potentiates cancer immunotherapy
…, M Huang, X Li, Y Zhao, X Zhang, Z Li, L Hu, J Tang… - Nature Cancer, 2024 - nature.com
Tumor-specific T cells are crucial in anti-tumor immunity and act as targets for cancer
immunotherapies. However, these cells are numerically scarce and functionally exhausted in the …
immunotherapies. However, these cells are numerically scarce and functionally exhausted in the …
[HTML][HTML] CD4+ T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy
…, J Guo, S Wen, Z Wang, Q Wu, J Tang… - … for immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Background Antitumor therapeutic vaccines are generally based on antigenic epitopes
presented by major histocompatibility complex (MHC-I) molecules to induce tumor-specific CD8+ …
presented by major histocompatibility complex (MHC-I) molecules to induce tumor-specific CD8+ …